---
$id: https://graph.org.ai/products/commodity/51294508
$type: Product
source: UNSPSC
code: "51294508"
title: "Litoxetine"
class: "51294500"
classTitle: "Antidepressant piperidines"
family: "51290000"
familyTitle: "Antidepressants"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Litoxetine

**UNSPSC Code**: 51294508
**Class**: [Antidepressant piperidines](Antidepressant piperidines.mdx)
**Family**: [Antidepressants](../Antidepressants.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antidepressant agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9980ST005G. European Medicines Agency schedules Litoxetine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08536MIG. Litoxetine generally arises in the molecular formula C16H19NO. The term LITOXETINE is an International Non-Proprietary Name or INN. LITOXETINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule litoxetine under HS 29333999 and SITC 51574. As of Q4 2014, LITOXETINE remains the US FDA Preferred Term for this commodity. Litoxetine bears US NLM identifiers UMLS ID C0165077 and NCI Concept Code C66021. SMILES: O(C1CCNCC1)Cc1cc2c(cc1)cccc2.

